This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

WMD Research Center Gives The Country's Biopreparedness Effort A "D" For Medical Countermeasures Development And Availability

Stocks in this article: PIP

ANNAPOLIS, Md., Oct. 12, 2011 /PRNewswire/ -- Today the Bipartisan WMD Terrorism Research Center (WMD Center) released its "Bio-Response Report Card" stating that the United States is not adequately prepared for the threat of a bioterrorism attack despite the attempts for improvements over the past decade.

During the 10 years since the initial anthrax attacks, the government has made great progress in certain areas but has failed to meet many of the bioterrorism preparedness objectives.  The WMD Center is giving the country a "D" for the development and availability of medical countermeasures for a large-scale attack.  While the current state of preparedness is unacceptable, the WMD Center also noted that investment in countermeasures would be among the most effective use of resources.  Among other benefits, investment in countermeasures would aid in the development of a more cost effective, faster-acting second-generation anthrax vaccine better suited to treating a large-scale attack.  A second-generation anthrax vaccine has the potential to greatly improve the United States' bioterrorism preparedness, but requires additional support and attention from the federal government to accelerate development of this necessary countermeasure.

"A second generation anthrax vaccine is vital considering the warnings from the US intelligence community of the imminent threat of bioterrorism.  We are pleased that the WMD Center has worked diligently to assess the status of the medical countermeasures arsenal and outline steps for improvement," said Eric Richman, President and CEO of PharmAthene.  "The anthrax attacks of 2001 are a harsh reminder of our vulnerability to this threat and PharmAthene looks forward to working with the federal government and other organizations to develop a strategic response to future bioterrorism threats."

The WMD Center is one of many organizations analyzing the attacks of 2001 to better prepare America for the future.  Tomorrow, October 13, at 9:00 a.m., the Center for American Progress (CAP) is holding a panel discussion on this subject, which will include high-level officials who coordinated the response to the attacks in 2001.  For more information about the CAP event visit: http://www.americanprogress.org/events/2011/10/anthraxrevisited.html

"I expect very compelling testimony tomorrow from these leaders who have first-hand experience responding to the threat of an anthrax attack," said Richman.  "Their concern about the current state of our nation's countermeasures should not be viewed lightly."

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs